CCS
LH icon

Crosspoint Capital Strategies’s Labcorp LH Stock Holding History

Crosspoint Capital Strategies’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-26,007
Closed -$2.41M – 510
2015
Q4 		$2.41M Buy
26,007
+25,774
+11,062% +$2.66M 0.63% 54
2015
Q3 		$22K Buy
+233
New +$24.1K 0.03% 338

Other funds holding LH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Crosspoint Capital Strategies's LH Position: Q1 2016 in Review

Crosspoint Capital Strategies sold out of Labcorp (LH) in Q1 2016, closing a stake of 26,007 shares — an estimated $2.41M sold.

Crosspoint Capital Strategies first reported a position in LH in Q3 2015 and held it in 2 quarters. The position peaked at $2.41M in Q4 2015. 631 funds tracked by Wall St. Rank hold LH as of Q1 2016.

  • Crosspoint Capital Strategies reported no remaining Labcorp position as of Q1 2016 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 26,007 Labcorp shares in Q1 2016, an estimated $2.41M.
  • Crosspoint Capital Strategies first reported a position in Labcorp in Q3 2015 and held it in 2 quarters.
  • Crosspoint Capital Strategies's Labcorp position peaked at $2.41M in Q4 2015.
  • 631 funds tracked by Wall St. Rank held Labcorp as of Q1 2016.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2016, filed 16 May 2016.